ALVIMOPAN
| Brand name | ENTEREG |
|---|---|
| Active ingredient | ALVIMOPAN |
| Strength | 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | May 2008 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8946262 | February 2030 | use U-1655 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.